Responses to E-Cigarette Advertising

Sponsor
University of Massachusetts, Worcester (Other)
Overall Status
Completed
CT.gov ID
NCT04249219
Collaborator
National Institute on Drug Abuse (NIDA) (NIH)
62
1
1
12.4
5

Study Details

Study Description

Brief Summary

While conventional cigarette use continues to decline among youth and young adults, e-cigarette (EC) use is on the rise. The use of ECs during young adulthood, particularly 18 years of age, is especially alarming because it is not only a critical period in development but also a time when tobacco use is established. Additionally, the tobacco industry targets individuals of this age with the hope that they will one day progress to using combustible cigarettes. Advertising may be one of the reasons leading young people to use ECs, and the Food and Drug Administration (FDA) now has the authority to regulate EC advertisement features. The goal of the study is to determine which EC ad features most strongly influence young adults' attitudes, susceptibility, and intentions to use ECs. Fifteen ads from the most popular EC brands that employ a brand, product descriptions, and modeling features were selected. Young adults who are susceptible to EC use will come into the lab and view these ads. During exposure, they will be assessed for real-time visual attention using eye-tracking, orienting responses using heart rate, and arousal using skin conductance as well as pre- and post-ad self-report measures of attitudes, susceptibility, and behavioral intentions. These factors will help determine the most high impact features, which will be associated with the greatest visual attention, orienting responses, and arousal levels and changes in attitudes. Findings from this study will provide public health officials important and urgently needed information as to what advertising features are contributing to the sharp rise in the use of ECs among young adults.

Condition or Disease Intervention/Treatment Phase
  • Other: Viewing e-cigarette ads
Early Phase 1

Study Design

Study Type:
Interventional
Actual Enrollment :
62 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Young Adults Responses to E-Cigarette Advertisement Features and the Effect of Restricting Features on Tobacco Use
Actual Study Start Date :
Aug 4, 2021
Actual Primary Completion Date :
Aug 15, 2022
Actual Study Completion Date :
Aug 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: E-Cigarette Ads

All individuals in the study will see the same e-cigarette advertisements presented in a random order.

Other: Viewing e-cigarette ads
All participants will see the same e-cigarette ads presented in a random order.

Outcome Measures

Primary Outcome Measures

  1. Attention to specific ad feature [Change in baseline (before intervention) vs. while viewing the ads (intervention)]

    Heart rate

  2. Arousal [Change in baseline (before intervention) vs. while viewing the ads (intervention)]

    Skin conductance

  3. Attention to specific ad feature [Duration of seconds spent on each ad feature during 10 second viewing window for each ad (intervention)]

    Eye-tracking

Secondary Outcome Measures

  1. Behavioral intentions [Change in baseline vs. post-ad viewing (intervention)]

    Self-report Behavioral Intentions (Intentions to Abstain) How likely it is that in the next 3 months, you will refrain from using e-cigarettes: completely and permanently 1 = definitely will not, 4 = definitely will How confident are you in your response? (1 = not at all confident, 7 = extremely confident) when you get lonely = definitely will not, 4 = definitely will How confident are you in your response? (1 = not at all confident, 7 = extremely confident) when you are with your friends who use them 1 = definitely will not, 4 = definitely will How confident are you in your response? (1 = not at all confident, 7 = extremely confident) when someone hands you an e-cigarette 1 = definitely will not, 4 = definitely will How confident are you in your response? (1 = not at all confident, 7 = extremely confident)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 26 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18-26 years old,

  • Fluent in English,

  • Biochemically confirmed abstinence combusted tobacco or marijuana (eCO: exhaled carbon monoxide <6 parts per million) at time of visit

  • Reporting never trying an e-cigarette, not even a puff OR reporting having used an e-cigarette in the past but has not used in the past 30 days

  • Susceptibility to EC use, will be determined using the Susceptibility to Use Tobacco Products questionnaire

Exclusion Criteria:
  • Younger than 18 years or older than 26 years

  • Not fluent in English

  • Not confirmed abstinent of combusted tobacco or marijuana

  • Use of an e-cigarette

  • Not susceptible to e-cigarette use

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Massachusetts Medical School Worcester Massachusetts United States 01605

Sponsors and Collaborators

  • University of Massachusetts, Worcester
  • National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: Elise M Stevens, PhD, UMass Medical School

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Elise Stevens, Assistant Professor, University of Massachusetts, Worcester
ClinicalTrials.gov Identifier:
NCT04249219
Other Study ID Numbers:
  • H00022646
  • K99DA046563
First Posted:
Jan 30, 2020
Last Update Posted:
Aug 17, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 17, 2022